The DOI matches its Crossref record.
Inhibitors of de Novo Nucleotide Biosynthesis as Drugs
Abstract
Potent inhibitors of enzymes catalyzing reactions in the de novo pathways for biosynthesis of purine and pyrimidine nucleotides are synthetic or natural-product analogues of pathway intermediates or, more recently, inhibitors rationally designed from a knowledge of the catalytic mechanism. Such inhibitors may be effective drugs against cancer, inflammatory disorders, or various infections. For human cancer, the purine pathway may be a better target for inhibition than the pyrimidine pathway, where toxic side effects are more apparent. Drugs such as methotrexate and 6-mercaptopurine have multiple sites of action, making it difficult to quantitatively predict their effects upon cells. Rational design of inhibitors based upon the X-ray structure of the target enzyme has the prospect of yielding drugs with only one site of action in human cells. Such a drug is VX-497, a potent inhibitor of the purine enzyme, IMP dehydrogenase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
A New View into the Regulation of Purine Metabolism: The Purinosome
Pedley, A. M., & Benkovic, S. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.009 · Cited by 576
Pyrimidine as Constituent of Natural Biologically Active Compounds
Lagoja, I. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490173 · Cited by 544
RUBIO, M. P., GERAGHTY, K. M., WONG, B. H. C., WOOD, N. T., CAMPBELL, D. G., MORRICE, N., & MACKINTOSH, C. (2004) · Biochemical Journal · doi:10.1042/bj20031797 · Cited by 442
Pyrimidine pathways in health and disease
LOFFLER, M., FAIRBANKS, L., ZAMEITAT, E., MARINAKI, A., & SIMMONDS, H. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.07.003 · Cited by 275
Metadata
- Authors
- Christopherson, R. I., Lyons, S. D., & Wilson, P. K.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-08-27
- Volume
- 35
- Issue
- 11
- Pages
- 961-971
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2148371056
- Cited by
- 162
- References
- 0
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of de Novo Nucleotide Biosynthesis as Drugs. https://app.cochat.ai/papers/10.1021/ar0000509
- The paper
- Christopherson, R. I., Lyons, S. D., & Wilson, P. K. (2002). Inhibitors of de Novo Nucleotide Biosynthesis as Drugs. Accounts of Chemical Research. https://doi.org/10.1021/ar0000509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.